Impact of hepatitis delta virus infection on waiting list outcomes: A competing-risks analysis

doi:10.4254/wjh.124709

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 10

This Article

(0)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Hepatol. Oct 27, 2026; 18(10): 124709
Published online Oct 27, 2026. doi: 10.4254/wjh.124709

Table 3 Cumulative incidence of waiting-list death and transplantation at 1 and 5 years, by group, 95%CI

Group	Death 1 year	Death 5 years	Gray P	Transplantation 1 year	Transplantation 5 years	Gray P value
Delta group vs non-delta viral group
Delta group	23.7 (17.1-30.2)	45.9 (38.1-53.8)	0.696	31.7 (24.6-38.8)	43.1 (35.4-50.9)	0.001
Non-delta viral group	15.7 (8.1-23.3)	42.9 (32.1-53.7)	0.696	19.2 (10.9-27.5)	21.7 (13.0-30.4)	0.001
Delta group vs HBV monoinfection group
Delta group	23.7 (17.1-30.2)	45.9 (38.1-53.8)	0.065	31.7 (24.6-38.8)	43.1 (35.4-50.9)	0.030
HBV monoinfection group	27.7 (10.9-44.5)	66.4 (47.3-85.5)	0.065	20.7 (5.5-35.9)	20.7 (5.5-35.9)	0.030

Values are Aalen-Johansen cumulative incidence. HBV: Hepatitis B virus.

Full Size Table

Citation: Peltec A, Buga D, Hotineanu A, Wedemeyer H. Impact of hepatitis delta virus infection on waiting list outcomes: A competing-risks analysis. World J Hepatol 2026; 18(10): 124709
URL: https://www.wjgnet.com/1948-5182/full/v18/i10/124709.htm
DOI: https://dx.doi.org/10.4254/wjh.124709

Peltec A, Buga D, Hotineanu A, Wedemeyer H. Impact of hepatitis delta virus infection on waiting list outcomes: A competing-risks analysis. World J Hepatol 2026; 18(10): 124709 [DOI: 10.4254/wjh.124709]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.